The Effect of Mipomersen in the Management of Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Clinical Trials

Background: Familial hypercholesterolemia (FH) lead to significant adverse effects in coronary arteries. Mipomersen is a second-generation antisense oligonucleotide that inhibits the synthesis of apolipoprotein B-100, an essential component of low density lipoprotein (LDL), and thus decreases the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Astaneh, Behrooz, Makhdami, Nima, Astaneh, Vala, Guyatt, Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304130/
https://www.ncbi.nlm.nih.gov/pubmed/34357325
http://dx.doi.org/10.3390/jcdd8070082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304130/
https://www.ncbi.nlm.nih.gov/pubmed/34357325
http://dx.doi.org/10.3390/jcdd8070082

Ejemplares similares